| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Net Income / (Loss): | -8,317,260 | -10,262,415 | -2,181,127 | -2,139,310 | -3,960,183 |
---|
Depreciation and amortization | 73,852 | 85,457 | 40,124 | 131,715 | 138,464 |
---|
Stock based compensation for services | 568,799 | 359,291 | 37,500 | 120,152 | 136,550 |
---|
Common Stock Recission | - | - | - | - | 1,500 |
---|
Net Issuance of options and warrants for services | - | - | 876,291 | 104,409 | 2 |
---|
Loss on disposal of assets | - | - | - | -33,484 | -40,099 |
---|
Prepaid expenses | -27,351 | 3,286 | -57,041 | -273 | -1,933 |
---|
Accrued interest - related party | - | - | 99,268 | -49,977 | 26,846 |
---|
Accounts payable and accrued liabilities | - | - | 142,835 | -519,588 | 92,887 |
---|
Right of use lease | - | - | - | -80,078 | -86,601 |
---|
Net cash used in operating activities | -2,244,833 | -1,844,227 | -921,446 | -2,465,250 | -2,036,143 |
---|
Net purchase of property and equipment | 18,037 | 8,000 | - | 216,390 | 138,170 |
---|
Patent Costs | - | - | - | 16,742 | 67,350 |
---|
Net cash from used in investing activities | -205,572 | -167,128 | -206,315 | -233,132 | -205,520 |
---|
Proceeds from exercise of warrants and options | 1,500 | - | 350,000 | 1 | 120,900 |
---|
Net proceeds from issuance of common stock | 3 | 1 | 887,380 | 2 | 1 |
---|
Net cash provided by financing activities | 2 | 2 | 1 | 4 | 1 |
---|
Net increase (decrease) in cash and cash equivalents | - | - | 175,949 | 878,085 | -952,763 |
---|
Interest | 512,046 | 65,355 | - | - | - |
---|